---
title: MASIMO Radical 7 and Laboratory Measurement
nct_id: NCT01706276
overall_status: COMPLETED
sponsor: Huazhong University of Science and Technology
study_type: OBSERVATIONAL
primary_condition: Major Hepatic Surgery
countries: China
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01706276.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01706276"
ct_last_update_post_date: 2013-11-20
last_seen_at: "2026-05-12T06:49:21.385Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# MASIMO Radical 7 and Laboratory Measurement

**NCT ID:** [NCT01706276](https://clinicaltrials.gov/study/NCT01706276)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 225
- **Lead Sponsor:** Huazhong University of Science and Technology
- **Conditions:** Major Hepatic Surgery
- **Start Date:** 2012-03
- **Completion Date:** 2013-07
- **CT.gov Last Update:** 2013-11-20

## Brief Summary

Present study aimed to evaluate the accuracy of Masimo Radical 7 to monitor hemoglobin concentrations through compared with laboratory measurement during major hepatic surgery, and to determine the source of discordance between two methods.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 75 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* adult patients
* American Society of Anesthesiologists Physical Status Ⅰor Ⅱ
* scheduled for potentially hemorrhagic major hepatic resection under general anesthesia
* requiring an arterial line

Exclusion Criteria:

* coagulopathy
* hemoglobinopathy
* cardiac dysrhythmias
* arrhythmia
* intracardiac shunt
* heart valve diseases
* tinea unguium
* arterio puncture failure
```

## Primary Outcomes

- **Hemoglobin measurement using the Masimo device** _(time frame: 0.5h after skin incision)_

## Secondary Outcomes

- **Change of Hemoglobin measurement using the Masimo device** _(time frame: 1h and 3h after skin incision)_

## Locations (1)

- Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

## Recent Field Changes (last 30 days)

- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.department of anaesthesiology, tongji hospital of tongji medical college, huazhong university of science and technology|wuhan|hubei|china` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01706276.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01706276*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*
